Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Wadler

Showing results (61-70 of 140) with videos related to

Pageof 14
Sort By:
Arthritis and Rheumatism|February 29, 2000
Rheumatoid arthritis exacerbation caused by exogenous interleukin-12E Peeva, A D Fishman, G Goddard, et al.
Investigational New Drugs|January 1, 1996
Phase I trial of high-dose infusional hydroxyurea, high-dose infusional 5-fluorouracil and recombinant interferon-alpha-2a in patients with advanced malignanciesS Wadler, H Haynes, R Schechner, et al.
Archives of Otolaryngology--Head & Neck Surgery|April 20, 1999
Pharyngeal transport dysfunction consequent to an organ-sparing protocolT Kotz, S Abraham, J J Beitler, et al.
Medical Oncology (Northwood, London, England)|March 1, 1995
Interferon-induced acute renal failure: a case report and literature reviewR Horowitz, D Glicklich, L B Sablay, et al.
Molecular Cell Biology Research Communications : MCBRC|October 18, 2000
Downregulation of cyclin D1 alters cdk 4- and cdk 2-specific phosphorylation of retinoblastoma proteinB Yu, M E Lane, R G Pestell, et al.
Archives of Otolaryngology--Head & Neck Surgery|July 21, 2004
Decreased short- and long-term swallowing problems with altered radiotherapy dosing used in an organ-sparing protocol for advanced pharyngeal carcinomaRichard V Smith, S Yedida Goldman, Jonathan J Beitler, et al.
Cancer Research|August 15, 1995
5-Ethoxy-2'-deoxyuridine, a novel substrate for thymidine phosphorylase, potentiates the antitumor activity of 5-fluorouracil when used in combination with interferon, an inducer of thymidine phosphorylase expressionE L Schwartz, N Baptiste, S Megati, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Interferon augments the cytotoxicity of hydroxyurea without enhancing its activity against the M2 subunit of ribonucleotide reductase: effects in wild-type and resistant human colon cancer cellsS Wadler, R Horowitz, J Rao, et al.
Cancer Research|June 19, 2001
c-myc/p53 interaction determines sensitivity of human colon carcinoma cells to 5-fluorouracil in vitro and in vivoD Arango, G A Corner, S Wadler, et al.
Cancer|December 15, 1986
Cardiac abnormalities in patients with diffuse malignant pleural mesotheliomaS Wadler, P Chahinian, W Slater, et al.
Pageof 14

Showing results (61-70 of 140) with videos related to

Sort By:
Pageof 14
Arthritis and Rheumatism|February 29, 2000
Rheumatoid arthritis exacerbation caused by exogenous interleukin-12E Peeva, A D Fishman, G Goddard, et al.
Investigational New Drugs|January 1, 1996
Phase I trial of high-dose infusional hydroxyurea, high-dose infusional 5-fluorouracil and recombinant interferon-alpha-2a in patients with advanced malignanciesS Wadler, H Haynes, R Schechner, et al.
Archives of Otolaryngology--Head & Neck Surgery|April 20, 1999
Pharyngeal transport dysfunction consequent to an organ-sparing protocolT Kotz, S Abraham, J J Beitler, et al.
Medical Oncology (Northwood, London, England)|March 1, 1995
Interferon-induced acute renal failure: a case report and literature reviewR Horowitz, D Glicklich, L B Sablay, et al.
Molecular Cell Biology Research Communications : MCBRC|October 18, 2000
Downregulation of cyclin D1 alters cdk 4- and cdk 2-specific phosphorylation of retinoblastoma proteinB Yu, M E Lane, R G Pestell, et al.
Archives of Otolaryngology--Head & Neck Surgery|July 21, 2004
Decreased short- and long-term swallowing problems with altered radiotherapy dosing used in an organ-sparing protocol for advanced pharyngeal carcinomaRichard V Smith, S Yedida Goldman, Jonathan J Beitler, et al.
Cancer Research|August 15, 1995
5-Ethoxy-2'-deoxyuridine, a novel substrate for thymidine phosphorylase, potentiates the antitumor activity of 5-fluorouracil when used in combination with interferon, an inducer of thymidine phosphorylase expressionE L Schwartz, N Baptiste, S Megati, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Interferon augments the cytotoxicity of hydroxyurea without enhancing its activity against the M2 subunit of ribonucleotide reductase: effects in wild-type and resistant human colon cancer cellsS Wadler, R Horowitz, J Rao, et al.
Cancer Research|June 19, 2001
c-myc/p53 interaction determines sensitivity of human colon carcinoma cells to 5-fluorouracil in vitro and in vivoD Arango, G A Corner, S Wadler, et al.
Cancer|December 15, 1986
Cardiac abnormalities in patients with diffuse malignant pleural mesotheliomaS Wadler, P Chahinian, W Slater, et al.
Pageof 14